rethinkTHC Search
Menu
Study breakdown

Cannabis smoking was linked to widespread DNA methylation changes that persisted even after quitting

Cross SectionalPreliminary evidence
The takeaway

In older adults, cannabis smoking was associated with thousands of epigenetic changes, many in aging and cancer-related pathways, and more than half of these changes persisted in former smokers who had quit.

Epigenetics researchers, pulmonologists, and public health professionals assessing long-term cannabis smoking effects.

5,915 shared gene changes in current and former smokers

What the researchers found

Current cannabis smokers showed 12,115 differentially methylated genes compared to never-smokers, while former cannabis smokers still showed 10,806 differentially methylated genes. Of these, 5,915 genes overlapped between current and former smokers. Fifty enriched pathways were shared between groups, heavily represented by aging and cancer-related pathways.

Why it matters

This is the first study to evaluate whether cannabis smoking cessation reverses epigenetic changes. The finding that most methylation disruptions persist after quitting suggests long-lasting biological effects that may not be undone by simply stopping use.

The numbers in context

N = 93 older adults. Current smokers: 12,115 differentially methylated genes. Former smokers: 10,806. Shared: 5,915 genes. 50 shared enriched pathways, heavily cancer- and aging-related.

How the study worked

Epigenome-wide DNA methylation analysis of peripheral blood from 93 older adults in the Canadian Cohort of Obstructive Lung Disease (CanCOLD), comparing current, former, and never cannabis smokers at FDR < 0.05.

What this study cannot tell us

Very small sample size (n=93) limits statistical power and generalizability. Cross-sectional design cannot track changes over time. Peripheral blood methylation may not reflect tissue-specific effects. Could not fully control for concurrent tobacco use.

How to read the evidence

First-of-its-kind analysis of cessation effects on cannabis-related epigenetic changes, but severely limited by very small sample size.

When this study was published

2025 publication

The bigger picture

While tobacco smoking is well known to cause persistent epigenetic changes linked to disease, this study suggests cannabis smoking may produce similarly durable epigenetic effects. The persistence of changes in former smokers is particularly noteworthy for long-term health risk assessment.

Questions still open

  • How long do these methylation changes persist after cessation? Do they eventually reverse with extended abstinence? Are these epigenetic changes functionally linked to cancer or accelerated aging outcomes?

Common questions

Do epigenetic changes from cannabis smoking go away after quitting?
Mostly no. Of the 12,115 differentially methylated genes in current smokers, 5,915 (about half) were also disrupted in former smokers, suggesting many cannabis-related epigenetic changes persist despite cessation.
What biological processes were affected?
Fifty shared enriched pathways were identified between current and former cannabis smokers, heavily represented by aging-related and cancer-related processes.

Read the original research

Cannabis smoking is associated with persistent epigenome-wide disruptions despite smoking cessation.

BMC pulmonary medicine, 25(1), 168

Citation

Cordero, Ana I Hernandez; Li, Xuan; Yang, Chen Xi; Ambalavanan, Amirtha; MacIsaac, Julie L; Kobor, Michael S; Doiron, Dany; Tan, Wan; Bourbeau, Jean; Sin, Don D; Duan, Qingling; Leung, Janice M. (2025). Cannabis smoking is associated with persistent epigenome-wide disruptions despite smoking cessation.. BMC pulmonary medicine, 25(1), 168. https://doi.org/10.1186/s12890-025-03634-9